• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Directories » FDA Approved Drugs » Effexor (venlafaxin HCL)

AND
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

Effexor (venlafaxin HCL)

  • Profile

Profile

Contact Information

Currently Enrolling Trials

    Show More

    General Information

    Effexor was approved for the treatment of depression in 1993. Effexor increases the levels of both serotonin and norepinephrine (two neurotransmitters though to cause the symptoms of depression) in the brain.

    Effexor's latest approval is for the treatment of anxiety disorder. It is estimated that 95% of people with depression experience at least one symptom of anxiety, including excessive or uncontrollable worry, apprehension, irritability, and muscle tension. Studies suggest that co-morbid depression and anxiety may have an impact on a patient's social functioning and is associated with a 30% to 60% increase in the utilization of healthcare services.

    Side Effects

    Some of the side effects of Effexor include the following:

    • headache
    • nausea
    • weight loss
    • constipation
    • blurry vision
    • diarrhea
    • dizziness
    • dry mouth
    • increased blood pressure

    Mechanism of Action

    Effexor affects various neuro chemicals in the body which are responsible for nervous system regulation. It inhibits specifically norepinephrine and serotonin reuptake, and also weakly inhibits dopamine reuptake. The net result is more neuro chemicals circulating in the nervous system.

    Additional Information

    Pregnancy and Breastfeeding Issues

    If you are pregnant, plan to become pregnant, or breastfeeding, discuss the potential risks of this or any medication with your doctor.

    It is also recommended that you talk to your doctor about Effexor if you have: high blood pressure, heart, liver, or kidney disease.

    Approval Date: 1999-03-01
    Company Name: Wyeth
    Back to Listings

    Upcoming Events

    • 26Jan

      Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

    • 27Jan

      Medical Device Clinical Trials in China: Latest Regulatory Developments

    • 11Feb

      Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

    • 23Mar

      Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

    • 26Apr

      MAGI's Clinical Research vConference — Spring 2021

    Featured Products

    • Regenerative Medicine – Steps to Accelerate Development : PDF

      Regenerative Medicine: Steps to Accelerate Development

    • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

      Clinical Trial Agreements: A Guide to Key Words and Phrases

    Featured Stories

    • Virtual Doctoer

      Simple Changes Can Make Trials More Patient Friendly

    • Drug approval

      Two-Thirds of Trial Subjects for Drug Approvals Are Outside the U.S.

    • VaccinewithNeedle-360x240.png

      Rules of Vaccine Approval May Be Changing, But Statistical Analysis Tools Remain Constant

    • AskTheExperts-360x240.png

      Ask the Experts: Trial Operations Adjustments in a Remote World

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell My Personal Information

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 617.948.5100 – Toll free 866.219.3440

    Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing